OpinionMay 5, 2021
How Human Challenge Trials Can Accelerate Vaccine Development
Studies in which subjects volunteer to be infected with a disease reduce the uncertainties and bottlenecks of other types of trials
Stories by Nicolas Noulin
Nicolas Noulin, Ph.D., is director of clinical science at hVIVO, a London-based company pioneering a technology platform that uses human models of disease such as common cold and influenza.